Paul Thompson, PhD

University of Southern California, Keck School of Medicine

Paul Thompson, PhD, co-leads AI4AD (the Artificial Intelligence for Alzheimer’s Disease Initiative) – a new $18M USD NIH initiative to apply deep learning to discover and understand drug targets based on whole genome sequence data and large-scale biobanks. Since 2009, Dr. Thompson has led the ENIGMA consortium (http://enigma.ini.usc.edu), a worldwide medical network of 1,000 institutions across 45 countries studying the major diseases of the brain, with MRI, diffusion MRI, resting state fMRI, EEG and genomics. ENIGMA published the largest neuroimaging studies of 9 major brain disorders and conditions – including PTSD, schizophrenia, bipolar disorder, major depression, ADHD, autism, and OCD. At USC, Paul Thompson is a Professor of Neurology, Psychiatry, Radiology, Pediatrics, Engineering, and Ophthalmology. Dr. Thompson obtained his M.A. in Mathematics and Greek & Latin Languages from Oxford University, England, and his Ph.D. in Neuroscience from UCLA. Dr. Thompson’s 1,600 published research papers combine the talents of researchers in mathematics, neuroimaging, and clinical neurology (see http://enigma.ini.usc.edu); in 2020, he was the 198th most cited scientist worldwide: http://www.webometrics.info/en/hlargerthan100

Session(s)


NOTE: If no session is listed above, this individual is a Chair or Co-chair of a session(s). Please see the individual session listings found in the Program for a full list of session participants.